Genesis Molecular AI · 14 hours ago
Cheminformatics and Machine Learning Intern
Greater Bend Area
Internship
Hybrid
InternGenesis Molecular AI is bringing together a world-class computational team to build out the industry's fastest and most accurate small molecule property predictions. They are seeking early career scientists to develop and apply machine-learning and cheminformatics methodologies to drive forward drug discovery programs.
BiotechnologyArtificial Intelligence (AI)Information Technology
Responsibilities
Lead a novel research project from ideation to conclusion, focused on improving our internal tools for potency and ADME prediction
Prototype novel approaches from recent publications. Design and execute large-scale experiments to validate promising avenues, using internal and public benchmarks
Work closely with our computer-aided drug discovery scientists and medicinal chemists to develop, benchmark, and deploy improvements to our drug discovery platform as it is applied to our internal and partnered drug discovery programs
Qualification
Required
A graduate student with a proven track record of developing cheminformatics tools and/or physics methods in contexts relevant to drug discovery
Experienced Python programmer with proven ability to navigate and contribute to complex codebases
Proficient ML practitioner, familiar with common architectures (understanding their strengths and tradeoffs) and with proven expertise in troubleshooting real-world applications
A detail-oriented data scientist skilled in managing diverse data sources
Familiarity with RDKit, Openeye and other cheminformatics libraries is a plus
Passionate about making a direct impact on drug-discovery programs and interacting with a diverse team of ML practitioners, medicinal chemists and drug-discovery scientists
Benefits
Dedicated mentorship from a senior researcher on our team who will partner with you, guide your project, and champion your growth.
A world-class, mission-driven team of good-hearted people across software, machine learning, computational chemistry, medicinal chemistry, and biology.
Company
Genesis Molecular AI
Genesis Therapeutics unifies AI and biotech to accelerate the discovery of new medicines.
Founded in 2019
51-200 employees
H1B Sponsorship
Genesis Molecular AI has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (3)
2024 (1)
2023 (1)
2022 (1)
Funding
Current Stage
Growth StageTotal Funding
$256.1MKey Investors
Andreessen HorowitzRock Springs Capital
2023-08-21Series B· $200M
2020-12-02Series A· $52M
2020-04-01Series Unknown
Leadership Team
Evan Feinberg
Founder and CEO
Aleksandra Faust
Senior Advisor
Recent News
Genetic Engineering News
2025-12-10
MIT Technology Review
2025-11-27
Company data provided by crunchbase